Patents by Inventor J. Peter Ruppersberg

J. Peter Ruppersberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of tinnitus
    Publication number: 20090093613
    Abstract: The invention relates to the use of substances which are at least partly blocking one ionotropic acetylcholine receptor of the inner ear and/or a calcium-activated potassium channel functionally associated with said acetylcholine receptor of the inner ear for the manufacturing of a pharmaceutical composition or medicament for the treatment of tinnitus.
    Type: Application
    Filed: November 20, 2007
    Publication date: April 9, 2009
    Applicant: TINNITUS FORSCHUNGS-UND ENTWICKLUNGS GMBH
    Inventors: J. Peter Ruppersberg, Bernd Fakler
  • Treatment of diseases with adamantane derivatives
    Publication number: 20040048892
    Abstract: The invention relates to the use of substances for the manufacturing of a pharmaceutical composition or medicament for the treatment of disturbances or illnesses which are linked to malfunction of an ionotropic acetylcholine receptor and/or a calcium-activated potassium channel functionally associated with said acetylcholine receptor, wherein said substance is at least one adamantane derivative.
    Type: Application
    Filed: July 30, 2003
    Publication date: March 11, 2004
    Inventors: J. Peter Ruppersberg, Bernd Fakler
  • Treatment of tinitus
    Publication number: 20040038884
    Abstract: The invention relates to the use of substances which are at least partly blocking one ionotropic acetylcholine receptor of the inner ear and/or a calcium-activated potassium channel functionally associated with said acetylcholine receptor of the inner ear for the manufacturing of a pharmaceutical composition or medicament for the treatment of tinnitus.
    Type: Application
    Filed: August 1, 2003
    Publication date: February 26, 2004
    Inventors: J. Peter Ruppersberg, Bernd Fakler
  • Method for treating diseases of the inner ear using adamantane derivatives
    Patent number: 6066652
    Abstract: Use of adamantane derivatives of the formula ##STR1## in which R1 and R2 are identical or different and can be hydrogen or straight-chained or branched alkyl groups having 1 to 6 carbon atoms, ortogether with the nitrogen atom can represent a heterocyclic group having 5 or 6 ring atoms,in which R3 and R4 are identical or different and can be hydrogen, straight-chained or branched alkyl groups having between 1 and 6 carbon atoms, cycloalkyl groups having 5 or 6 carbon atoms or a phenyl group, and in which R5 is hydrogen or a straight-chained or branched alkyl group having between 1 and 6 carbon atoms for treating diseases of the inner ear.
    Type: Grant
    Filed: June 12, 1998
    Date of Patent: May 23, 2000
    Assignee: Tinnitus Forschungs-und Entwicklungs GmbH
    Inventors: Hans Peter Zenner, J. Peter Ruppersberg, Andreas Busch